Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solian Solution in Acute Schizophrenia
NCT00245674Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amisulpride in schizophrenia, sponsored by Sanofi. Started Jun 2005; status: completed.
02
Drugs
amisulpride
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00245674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245674.